Insider Selling: Illumina SVP Sells 1,875 Shares of Stock (ILMN)
Illumina (NASDAQ:ILMN) SVP Gregory Heath sold 1,875 shares of the stock on the open market in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $82.00, for a total value of $153,750.00. Following the completion of the transaction, the senior vice president now directly owns 26,740 shares in the company. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
A number of analysts have recently weighed in on ILMN shares. Analysts at Wells Fargo & Co. initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Monday. They set an “outperform” rating on the stock. Separately, analysts at Bank of America Corp. set a $90.00 price target on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 22nd. They now have a “buy” rating on the stock. Finally, analysts at Janney Montgomery Scott initiated coverage on shares of Illumina (NASDAQ:ILMN) in a research note to investors on Thursday, August 15th. They set a “neutral” rating on the stock.
One research analyst has rated the stock with a sell rating, eight have issued a hold rating and eight have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus price target of $73.81.
Illumina (NASDAQ:ILMN) traded down 0.49% on Thursday, hitting $83.52. The stock had a trading volume of 999,157 shares. Illumina has a 52 week low of $44.78 and a 52 week high of $84.50. The stock’s 50-day moving average is $79.0 and its 200-day moving average is $67.84. The company has a market cap of $10.450 billion and a P/E ratio of 98.74.
Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, July 23rd. The company reported $0.43 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.40 by $0.03. The company had revenue of $346.09 million for the quarter, compared to the consensus estimate of $331.77 million. During the same quarter last year, the company posted $0.40 earnings per share. Illumina’s revenue was up 23.3% compared to the same quarter last year. Analysts expect that Illumina will post $1.72 EPS for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.